Variables | |
---|---|
Age (years) | 70 (41–85) |
Sex (male/female) | 153 (81%)/36 (19%) |
BMI | 22.1 (13.2–34.5) |
Lymphocyte count (/mm3) | 1400 (320–3950) |
Neutrophil count (/mm3) | 3020 (820–8780) |
Platelet count (103/µl) | 18.3 (4.1–219.0) |
Albumin (g/dl) | 3.8 (2.3–5.3) |
Total bilirubin (mg/dl) | 0.6 (0.2–2.5) |
PT-INR | 1.05 (0.87–1.41) |
Child–Pugh A/B/C | 178 (94.2%) / 11 (5.8%) / 0 |
AFP (ng/ml) | 12 (1–253,875) |
DCP (mAU/ml) | 115 (1–286,400) |
ICG R15 (%) | 12.9 (0.3–76.3) |
LHL15 | 0.935 (0.679–0.987) |
Tumor size (cm) | 4.0 (0.5–24.0) |
Multiple tumor | 49 (25.9%) |
BCLC stage 0/A/B/C | 17 / 121 / 38 / 13 |
Milan criteria within / beyond | 107 (56.6%) / 82 (43.4%) |
PNI | 45.4 (26.0–60.0) |
NLR | 2.06 (0.52–14.2) |
PLR | 135 (33–1685) |
ALBI grade 1 / 2 / 3 | 85 (45%) / 99 (52%) / 5 (3%) |
Underlying liver disease | |
NBNC / HBV / HCV | 85 (45%) / 26 (14%) / 78 (41%) |